Company
Headquarters: Shanghai, China
Employees: 2,771
CN¥9.55 Billion
CNY as of Jan. 1, 2026
US$1.36 Billion
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $222.61 B |
| Danaher | $164.98 B |
| Siemens Healthineers AG | $57.84 B |
| IDEXX Laboratories, Inc. | $53.62 B |
| Lonza Group Ltd | $47.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥7.40 B |
| EBITDA | CN¥445.3 M |
| Gross Profit TTM | CN¥1.65 B |
| Profit Margin | -2.13% |
| Operating Margin | 3.21% |
| Quarterly Revenue Growth | -11.90% |
Shanghai Runda Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: SSE: 603108 wb_incandescent